Profile data is unavailable for this security.
About the company
Allergy Therapeutics plc is a United Kingdom-based integrated specialty pharmaceutical company. The Company is focused on the treatment and diagnosis of allergic disorders, including aluminum-free immunotherapy vaccines that have the potential to cure disease. The Company sells proprietary and third-party products from its subsidiaries in nine European countries and via distribution agreements in an additional ten countries. Its pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Its pipeline candidates include Grass MATA MPL, Birch MATA MPL, Ragweed MATA, Bee Venom SCIT, Wasp Venom SCIT, Ragweed MATA MPL, Trees MATA, Trees MATA MPL, Peanut SCIT and others. Its commercial portfolio of products includes Pollinex, Venomil and Acarovac. It operates in Austria, Germany, Italy, the Netherlands, Spain, Switzerland, and the United Kingdom.
- Revenue in GBP (TTM)53.26m
- Net income in GBP-50.22m
- Incorporated2004
- Employees635.00
- LocationAllergy Therapeutics PLCDominion WayWORTHING BN14 8SAUnited KingdomGBR
- Phone+44 19 0384 4700Fax+44 19 0384 4726
- Websitehttps://www.allergytherapeutics.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Eco Animal Health Group Plc | 88.46m | -1.62m |
Scancell Holdings Plc | 0.00 | -11.32m |
Futura Medical PLC | 3.10m | -6.51m |
Faron Pharmaceuticals Oy | 0.00 | -26.46m |
Allergy Therapeutics plc | 53.26m | -50.22m |
4Basebio PLC | 354.00k | -6.28m |
Animalcare Group Plc | 74.35m | 1.20m |
Avacta Group Plc | 16.03m | -42.08m |
Alliance Pharma plc | 170.05m | -7.06m |
hVIVO PLC | 56.04m | 16.12m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
JPMorgan Chase Bank, NA (Investment Management)as of 01 Mar 2024 | 124.00m | 2.60% |
Hargreaves Lansdown Asset Management Ltd.as of 01 Mar 2024 | 16.00m | 0.34% |
West Yorkshire Pension Fundas of 01 Mar 2024 | 13.88m | 0.29% |
Panmure Gordon (UK) Ltd.as of 01 Mar 2024 | 10.22m | 0.21% |
IG Markets Ltd.as of 01 Mar 2024 | 8.95m | 0.19% |
HSBC Global Asset Management (UK) Ltd.as of 01 Mar 2024 | 4.69m | 0.10% |
Santander Asset Management SA SGIICas of 01 Mar 2024 | 3.13m | 0.07% |
Raiffeisen Kapitalanlage-Gesellschaft mbHas of 01 Mar 2024 | 2.03m | 0.04% |
iDealing.com Ltd.as of 01 Mar 2024 | 1.42m | 0.03% |
Bank Julius B�r & Co. AGas of 01 Mar 2024 | 1.39m | 0.03% |